Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Anti-myelin oligodendrocyte glycoprotein (MOG) antibody].
[Treatment of multiple sclerosis: new approaches to treat case by case].
Alarmin' Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent Responses.
Therapeutic Cleavage of Anti-Aquaporin-4 Autoantibody in Neuromyelitis Optica by an Igg-Selective Proteinase.
The magnetic resonance imaging 'rule of five': predicting the occurrence of relapse.
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).
[History of Guillain-Barré Syndrome].
Microglia Plasticity During Health and Disease: An Immunological Perspective.
Efficacy of rituximab in refractory neuromyelitis optica.
Secondary B Cell Receptor Diversification Is Necessary for T Cell Mediated Neuro-Inflammation during Experimental Autoimmune Encephalomyelitis.
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one - Time administration of encephalitogenic T cells.
Microglia in Health and Disease.
Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.
A study of experimental autoimmune encephalomyelitis in dogs; as a disease model for canine necrotizing encephalitis.
The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
Prostacyclin Prevents Pericyte Loss and Demyelination Induced by Lysophosphatidylcholine in the Central Nervous System.
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis.
Single-step grafting of aminooxy-peptides to hyaluronan: A simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis.
An acute transverse myelitis attack after total body irradiation: a rare case.
Pages
« first
‹ previous
…
617
618
619
620
621
622
623
624
625
…
next ›
last »